| 2982- | RES, | The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1 |
| - | in-vitro, | Melanoma, | MSTO-211H |
| 2983- | RES, | Resveratrol Improves Diabetic Retinopathy via Regulating MicroRNA-29b/Specificity Protein 1/Apoptosis Pathway by Enhancing Autophagy |
| - | in-vitro, | Nor, | NA |
| 2984- | RES, | Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue |
| - | in-vivo, | Nor, | NA |
| 2985- | RES, | Resveratrol Inhibits Diabetic-Induced Müller Cells Apoptosis through MicroRNA-29b/Specificity Protein 1 Pathway |
| - | in-vivo, | Nor, | NA | - | vitro+vivo, | Diabetic, | NA |
| 2986- | RES, | Effect of the natural compound trans‑resveratrol on human MCM4 gene transcription |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | AML, | HL-60 |
| 2987- | RES, | Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1 |
| - | in-vivo, | Nor, | NA |
| 2988- | RES, | The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation |
| - | in-vitro, | HCC, | HUH7 |
| 2991- | RES, | Chemo, | Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells |
| - | in-vitro, | Melanoma, | MSTO-211H | - | in-vitro, | Nor, | MeT5A |
| 101- | RES, | Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis |
| - | in-vitro, | GC, | SGC-7901 |
| 105- | RES, | QC, | The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell |
| - | in-vitro, | Pca, | PANC1 |
| 104- | RES, | QC, | Resveratrol and Quercetin in Combination Have Anticancer Activity in Colon Cancer Cells and Repress Oncogenic microRNA-27a |
| - | in-vitro, | Colon, | HT-29 |
| 103- | RES, | CUR, | QC, | The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice |
| - | vitro+vivo, | BC, | 4T1 |
| 102- | RES, | Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway |
| - | in-vitro, | PC, | MIA PaCa-2 |
| 1047- | RES, | Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells |
| - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 967- | RES, | Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer |
| - | Analysis, | PC, | NA |
| 882- | RES, | Resveratrol: A Double-Edged Sword in Health Benefits |
| - | Review, | NA, | NA |
| 880- | RES, | Forkhead Proteins Are Critical for Bone Morphogenetic Protein-2 Regulation and Anti-tumor Activity of Resveratrol |
| - | in-vitro, | BC, | MDA-MB-231 |
| 881- | RES, | Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | Pca, | DU145 |
| 879- | RES, | Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it |
| - | in-vitro, | CRC, | HCT116 |
| 924- | RES, | Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells |
| - | in-vitro, | OS, | U2OS | - | in-vitro, | Lung, | A549 |
| 878- | RES, | Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression |
| - | vitro+vivo, | CRC, | LoVo |
| 877- | RES, | Resveratrol Inhibits Invasion and Metastasis of Colorectal Cancer Cells via MALAT1 Mediated Wnt/β-Catenin Signal Pathway |
| - | in-vitro, | CRC, | LoVo | - | in-vitro, | CRC, | HCT116 |
| 885- | RES, | Resveratrol induces intracellular Ca2 + rise via T-type Ca2 + channels in a mesothelioma cell line |
| - | in-vitro, | RCC, | REN | - | in-vitro, | Nor, | MeT5A |
| 871- | RES, | CUR, | QC, | The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | BC, | 4T1 |
| 884- | RES, | PTS, | Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells |
| - | in-vitro, | Cerv, | HeLa |
| 883- | RES, | Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy |
| 993- | RES, | Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells |
| - | in-vitro, | CRC, | Caco-2 | - | in-vivo, | Nor, | HCEC 1CT |
| 4706- | RES, | Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications |
| - | Review, | Nor, | NA |
| 4657- | RES, | Resveratrol, cancer and cancer stem cells: A review on past to future |
| - | Review, | Var, | NA |
| 4669- | RES, | Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis |
| - | in-vitro, | Cerv, | NA |
| 4668- | RES, | Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation |
| - | in-vitro, | NPC, | NA |
| 4667- | RES, | CUR, | SFN, | Physiological modulation of cancer stem cells by natural compounds: Insights from preclinical models |
| - | Review, | Var, | NA |
| 4666- | RES, | Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway |
| - | in-vitro, | Lung, | H23 | - | in-vitro, | Lung, | H292 | - | in-vitro, | Lung, | A549 |
| 4663- | RES, | Exploring resveratrol’s inhibitory potential on lung cancer stem cells: a scoping review of mechanistic pathways across cancer models |
| - | Review, | Var, | NA |
| 4670- | RES, | CUR, | EGCG, | TQ, | Targeting aging pathways with natural compounds: a review of curcumin, epigallocatechin gallate, thymoquinone, and resveratrol |
| - | Review, | Nor, | NA |
| 4662- | RES, | A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H460 |
| 4289- | RES, | Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells |
| - | in-vitro, | AD, | NA |
| 4288- | RES, | Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β |
| - | in-vivo, | AD, | NA |
| 4287- | RES, | Resveratrol targeting tau proteins, amyloid-beta aggregations, and their adverse effects: An updated review |
| - | Review, | AD, | NA |
| 4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4285- | RES, | Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy |
| - | in-vivo, | AD, | NA |
| 4284- | RES, | Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex |
| - | in-vitro, | AD, | HEK293 | - | NA, | Stroke, | NA | - | in-vivo, | AD, | NA |
| 4570- | RF, | Role of Mitochondria in the Oxidative Stress Induced by Electromagnetic Fields: Focus on Reproductive Systems |
| - | Review, | Nor, | NA |
| 4357- | RF, | Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies |
| - | Review, | Var, | NA |
| 3729- | RF, | Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease |
| - | in-vivo, | AD, | NA |
| 3730- | RF, | Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development |
| - | Review, | AD, | NA |
| 3731- | RF, | Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice |
| - | in-vivo, | AD, | NA |
| 3732- | RF, | Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit |
| - | in-vivo, | AD, | NA |
| - | in-vivo, | AD, | NA |
| 3736- | RF, | Long-term electromagnetic pulse exposure induces Abeta deposition and cognitive dysfunction through oxidative stress and overexpression of APP and BACE1 |
| - | in-vivo, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid